 | • レポートコード：D0GIR-04221 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗ウイルス薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗ウイルス薬の種類別市場規模（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター）、用途別市場規模（肝炎治療、HIV/AIDS治療、ヘルペス治療、インフルエンザ治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、AbbVie、Novartis、Johnson & Johnson、GlaxoSmithKline、Merck、Gilead Sciences、Bristol-Myers Squibb ・地域別グローバル市場分析 2015年-2020年 ・抗ウイルス薬の北米市場（アメリカ、カナダ、メキシコ） ・抗ウイルス薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗ウイルス薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗ウイルス薬の南米市場（ブラジル、アルゼンチン） ・抗ウイルス薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター ・用途別分析：肝炎治療、HIV/AIDS治療、ヘルペス治療、インフルエンザ治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 47600 million by 2025, from USD 42060 million in 2019.
The Antiviral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antiviral Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antiviral Drugs market has been segmented into
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
By Application, Antiviral Drugs has been segmented into:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antiviral Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Antiviral Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antiviral Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Antiviral Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antiviral Drugs Market Share Analysis
Antiviral Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antiviral Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antiviral Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Antiviral Drugs are:
Roche
AbbVie
Novartis
Johnson & Johnson
GlaxoSmithKline
Merck
Gilead Sciences
Bristol-Myers Squibb
Among other players domestic and global, Antiviral Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiviral Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antiviral Drugs, with price, sales, revenue and global market share of Antiviral Drugs in 2018 and 2019.
Chapter 3, the Antiviral Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiviral Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antiviral Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antiviral Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antiviral Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antiviral Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 Fusion Inhibitors
1.2.5 Immune System Modulators
1.3 Market Analysis by Application
1.3.1 Overview: Global Antiviral Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.4 Overview of Global Antiviral Drugs Market
1.4.1 Global Antiviral Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gilead Sciences SWOT Analysis
2.7.4 Gilead Sciences Product and Services
2.7.5 Gilead Sciences Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb SWOT Analysis
2.8.4 Bristol-Myers Squibb Product and Services
2.8.5 Bristol-Myers Squibb Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antiviral Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antiviral Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antiviral Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Antiviral Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antiviral Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antiviral Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antiviral Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Antiviral Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Antiviral Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antiviral Drugs Sales and Growth Rate (2015-2020)
4.5 South America Antiviral Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antiviral Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antiviral Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Antiviral Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Antiviral Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Antiviral Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Antiviral Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Antiviral Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antiviral Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Antiviral Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antiviral Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Antiviral Drugs Sales and Growth Rate (2015-2020)
6.3 UK Antiviral Drugs Sales and Growth Rate (2015-2020)
6.4 France Antiviral Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Antiviral Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Antiviral Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antiviral Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antiviral Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antiviral Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Antiviral Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Antiviral Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Antiviral Drugs Sales and Growth Rate (2015-2020)
7.5 India Antiviral Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antiviral Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Antiviral Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antiviral Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Antiviral Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Antiviral Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antiviral Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Antiviral Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antiviral Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antiviral Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antiviral Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antiviral Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Antiviral Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Antiviral Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Antiviral Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antiviral Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Antiviral Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Antiviral Drugs Price by Type (2015-2020)
11 Global Antiviral Drugs Market Segment by Application
11.1 Global Antiviral Drugs Sales Market Share by Application (2015-2020)
11.2 Global Antiviral Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Antiviral Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antiviral Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Antiviral Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Antiviral Drugs Market Forecast (2021-2025)
12.2.2 Europe Antiviral Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antiviral Drugs Market Forecast (2021-2025)
12.2.4 South America Antiviral Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antiviral Drugs Market Forecast (2021-2025)
12.3 Antiviral Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Antiviral Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Antiviral Drugs Market Share Forecast by Type (2021-2025)
12.4 Antiviral Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Antiviral Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Antiviral Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antiviral Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antiviral Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antiviral Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Antiviral Drugs Major Business
Table 9. Roche Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Roche SWOT Analysis
Table 11. Roche Antiviral Drugs Product and Services
Table 12. Roche Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Antiviral Drugs Major Business
Table 15. AbbVie Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 16. AbbVie SWOT Analysis
Table 17. AbbVie Antiviral Drugs Product and Services
Table 18. AbbVie Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Antiviral Drugs Major Business
Table 21. Novartis Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Antiviral Drugs Product and Services
Table 24. Novartis Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Antiviral Drugs Major Business
Table 27. Johnson & Johnson Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Antiviral Drugs Product and Services
Table 30. Johnson & Johnson Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Antiviral Drugs Major Business
Table 33. GlaxoSmithKline Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 34. GlaxoSmithKline SWOT Analysis
Table 35. GlaxoSmithKline Antiviral Drugs Product and Services
Table 36. GlaxoSmithKline Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Antiviral Drugs Major Business
Table 39. Merck Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Merck SWOT Analysis
Table 41. Merck Antiviral Drugs Product and Services
Table 42. Merck Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Gilead Sciences Antiviral Drugs Major Business
Table 45. Gilead Sciences Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Gilead Sciences SWOT Analysis
Table 47. Gilead Sciences Antiviral Drugs Product and Services
Table 48. Gilead Sciences Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 50. Bristol-Myers Squibb Antiviral Drugs Major Business
Table 51. Bristol-Myers Squibb Antiviral Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Bristol-Myers Squibb SWOT Analysis
Table 53. Bristol-Myers Squibb Antiviral Drugs Product and Services
Table 54. Bristol-Myers Squibb Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Antiviral Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Antiviral Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Antiviral Drugs Sales by Regions (2015-2020) (K Units)
Table 58. Global Antiviral Drugs Sales Market Share by Regions (2015-2020)
Table 59. Global Antiviral Drugs Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Antiviral Drugs Sales by Countries (2015-2020) (K Units)
Table 61. North America Antiviral Drugs Sales Market Share by Countries (2015-2020)
Table 62. North America Antiviral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Table 64. Europe Antiviral Drugs Sales by Countries (2015-2020) (K Units)
Table 65. Europe Antiviral Drugs Sales Market Share by Countries (2015-2020)
Table 66. Europe Antiviral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Antiviral Drugs Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Antiviral Drugs Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Antiviral Drugs Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Antiviral Drugs Sales by Countries (2015-2020) (K Units)
Table 71. South America Antiviral Drugs Sales Market Share by Countries (2015-2020)
Table 72. South America Antiviral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Antiviral Drugs Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Antiviral Drugs Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Antiviral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Global Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 79. Global Antiviral Drugs Sales Share by Type (2015-2020)
Table 80. Global Antiviral Drugs Revenue by Type (2015-2020) (USD Million)
Table 81. Global Antiviral Drugs Revenue Share by Type (2015-2020)
Table 82. Global Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 83. Global Antiviral Drugs Sales Share by Application (2015-2020)
Table 84. Global Antiviral Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Antiviral Drugs Market Share Forecast by Regions (2021-2025)
Table 86. Global Antiviral Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Antiviral Drugs Market Share Forecast by Type (2021-2025)
Table 88. Global Antiviral Drugs Sales Forecast by Application (2021-2025)
Table 89. Global Antiviral Drugs Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antiviral Drugs Picture
Figure 2. Global Sales Market Share of Antiviral Drugs by Type in 2019
Figure 3. Reverse Transcriptase Inhibitors Picture
Figure 4. Protease Inhibitors Picture
Figure 5. Fusion Inhibitors Picture
Figure 6. Immune System Modulators Picture
Figure 7. Antiviral Drugs Sales Market Share by Application in 2018
Figure 8. Hepatitis Therapeutics Picture
Figure 9. HIV/AIDS Therapeutics Picture
Figure 10. Herpes Therapeutics Picture
Figure 11. Influenza Therapeutics Picture
Figure 12. Global Antiviral Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Antiviral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Antiviral Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Antiviral Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Antiviral Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Antiviral Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Antiviral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Antiviral Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Antiviral Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Antiviral Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Antiviral Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Antiviral Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Antiviral Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Antiviral Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Antiviral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Antiviral Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Antiviral Drugs Sales Market Share by Countries in 2018
Figure 49. North America Antiviral Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Antiviral Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Antiviral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Antiviral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Antiviral Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Antiviral Drugs Revenue Market Share by Regions 2019
Figure 65. China Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Antiviral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Antiviral Drugs Sales Market Share by Countries in 2019
Figure 72. South America Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Antiviral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Antiviral Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Antiviral Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Antiviral Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Antiviral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Antiviral Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Antiviral Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Antiviral Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Antiviral Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Antiviral Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Antiviral Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Antiviral Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
インフルエンザ（インフルエンザ）抗ウイルス薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza (Flu) Antiviral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 頭頸部がん治療薬/治療剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …
- COVID-19用特定抗ウイルス薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Specific Antiviral Drugs for COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- ペプチド治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Peptide Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 双極性障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bipolar Disorder Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.9% in the forecast period of 2020 to 2025 and will expected to reach USD 4283.5 million by 2025, from USD 3966.9 million in 2019. The Bipola…